Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)
NCT ID: NCT00653809
Last Updated: 2012-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2007-06-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861
Gene Expression In Pregnancies Complicated by Preeclampsia
NCT00919360
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393
Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia.
NCT01907620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A, 1, I
Caucasian women without preeclampsia or PIH, delivering their first child
No interventions assigned to this group
A, 1, II
Caucasian women with preeclampsia or PIH, delivering their first child
No interventions assigned to this group
A, 2, I
African-american women without preeclampsia or PIH, delivering their first child
No interventions assigned to this group
A, 2, II
African-American women with preeclampsia or PIH, delivering their first child
No interventions assigned to this group
B, 1, I
Caucasian women without preeclampsia or PIH, delivering at least their second child
No interventions assigned to this group
B, 1, II
Caucasian women with preeclampsia or PIH, delivering at least their second child
No interventions assigned to this group
B, 2, I
African-american women without preeclampsia or PIH, delivering at least their second child
No interventions assigned to this group
B, 2, II
African-american women with preeclampsia or PIH, delivering at least their second child
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant
* Between ages of 18 - 40 years of age
Exclusion Criteria
* Drug or alcohol abuse during pregnancy
* Obesity
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Office of Minority Health
UNKNOWN
Mississippi Institute for Improvement of Geographic Minority Health
UNKNOWN
University of Mississippi Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kedra Wallace
Postdoc Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kedra L Wallace, PhD
Role: PRINCIPAL_INVESTIGATOR
Obstetrics & Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of MS Medical Center
Jackson, Mississippi, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-0065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.